↓ Skip to main content

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting

Overview of attention for article published in Frontiers in Pharmacology, July 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
5 X users
patent
1 patent
facebook
4 Facebook pages

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
Published in
Frontiers in Pharmacology, July 2016
DOI 10.3389/fphar.2016.00221
Pubmed ID
Authors

Erin M. Rock, Linda A. Parker

Abstract

Despite the advent of classic anti-emetics, chemotherapy-induced nausea is still problematic, with vomiting being somewhat better managed in the clinic. If post-treatment nausea and vomiting are not properly controlled, anticipatory nausea-a conditioned response to the contextual cues associated with illness-inducing chemotherapy-can develop. Once it develops, anticipatory nausea is refractive to current anti-emetics, highlighting the need for alternative treatment options. One of the first documented medicinal uses of Δ(9)-tetrahydrocannabinol (Δ(9)-THC) was for the treatment of chemotherapy-induced nausea and vomiting (CINV), and recent evidence is accumulating to suggest a role for the endocannabinoid system in modulating CINV. Here, we review studies assessing the therapeutic potential of cannabinoids and manipulations of the endocannabinoid system in human patients and pre-clinical animal models of nausea and vomiting.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Austria 1 1%
Unknown 72 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 15%
Researcher 9 12%
Other 9 12%
Student > Ph. D. Student 9 12%
Student > Doctoral Student 5 7%
Other 11 15%
Unknown 19 26%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Agricultural and Biological Sciences 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Biochemistry, Genetics and Molecular Biology 5 7%
Psychology 3 4%
Other 11 15%
Unknown 24 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2020.
All research outputs
#5,040,842
of 23,939,410 outputs
Outputs from Frontiers in Pharmacology
#2,292
of 17,788 outputs
Outputs of similar age
#88,894
of 371,128 outputs
Outputs of similar age from Frontiers in Pharmacology
#24
of 143 outputs
Altmetric has tracked 23,939,410 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,788 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 143 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.